APOE and atherosclerosis: Nevertheless, our results here demonstrate that saringosterol treatment had favorable rather than adverse effects on the serum and hepatic TG levels in atherosclerotic ApoE−/− mice, suggesting that saringosterol is both safe and effective and could be tested for the treatment of atherosclerosis in the future.